1Legro RS.Polycystic ovary syndrome:phenotype to genotype[J].Endocrinol Metab Clin North Am,1999,28(2):379-396.
2Velazquez EM,Mendoza S,Hamer T,et a1.Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia,insulin resistance,hyperandrogenemia,and systolic blood pressure,while facilitating normal menses and pregnancy[J].Metabolism,1994,43:647-654.
3Azziz R,Carmina E,Dewailly D,et a1.The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome[J].Fertil Steril,2009,91(2):456-488.
4Vrbikova J,Hainer V.Obesity and polycystic ovary syndrome[J].Obes Facts,2009,2:26-35.
5Novak ER,Goldberg B,Jones GS,et al.Enzyme histochemistry of the menopausal ovary associated with normal and abnormal endometrium[J].Am J Obstet Gynecol,1965,93:669-682.
6Plouffe L.Disorders of excessive hair growth in the adolescent.Obstet[J].Gynecol Clin North Am,2000,27:79-99.
7Nelson VL,Qin KN,Rosenfield RL,et al.The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome[J].J Clin Endocrinol Metab,2001,86:5925-5933.
8Ciaraldi TP,el-Roeiy A,Madar Z,et al.Cellular mechanisms of insulin resistance in polycystic ovarian syndrome[J].J Clin Endocrinol Metab,1992,75(2):577-583.
9Hogeveen KN,Talikka M.Human sex hormone-binding globulin promoter activity is influenced by a (TAAAA)n repeat element within an Alu sequence[J].J Bio Chem,2001,276:36383-36390.
